SEARCH

SEARCH BY CITATION

References

  • 1
    Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy. Cancer Res 1990; 50: 6502.
  • 2
    Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among US veterans. Cancer 1993; 72: 1369.
  • 3
    Longnecker MP. Alcohol consumption and risk of cancer in humans: an overview. Alcohol 1995; 12: 87.
  • 4
    Castelli E, Hrelia P, Maffei F, et al. Indicators of genetic damage in alcoholics: reversibility after alcohol abstinence. Hepatogastroenterology 1999; 46: 1664.
  • 5
    Kato I, Nomura AMY. Alcohol in the etiology of upper aerodigestive tract cancer. Oral Oncol Eur J Cancer 1994; 30B: 75.
  • 6
    Parkin DM, Pisani P, López AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Int J Cancer 1994; 59: 494.
  • 7
    Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer 2002; 99: 245.
  • 8
    Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989; 139: 194.
  • 9
    Goldstein DJ, Austin JHM, Zuech N, et al. Carcinoma of the lung after heart transplantation. Transplantation 1996; 62: 772.
  • 10
    Shiffman S, Fischer LA, Paty JA, Gnys M, Hickox M, Kassel JD. Drinking and smoking: a field study of their association. Ann Behav Med 1994; 16: 203.
  • 11
    Perkins KA, Bohay J, Meylahn EN, Wing RR, Mathews KA, Kuller LH. Diet, alcohol intake, and physical activity as a function of smoking status in middle-aged women. Health Psychol 1993; 12: 410.
  • 12
    Keenan RM, Hatsukami DK, Pickens RW, Gust SW, Strelow LJ. The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and natural environment. Psychopharmacology (Berl) 1990; 100: 77.
  • 13
    Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767.
  • 14
    Ehlers SL, Rodriguez JR, Widows MR, Reed AI, Nelson DR. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 2004; 10: 412.
  • 15
    Duvoux C, Delacroix I, Richardet JP, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67: 418.
  • 16
    Jiménez C, Rodríguez D, Marqués E, et al. De novo tumors after orthotopic liver transplantation. Transplant Proc 2002; 34: 297.
  • 17
    Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193.
  • 18
    Romano DR, Jiménez C, Rodríguez F, et al. Orthotopic liver transplantation in alcoholic cirrhosis. Transplant Proc 1999; 31: 2491.
  • 19
    Jiménez C, Marqués E, Loinaz C, et al. Upper aerodigestive tract and lung tumors after liver transplantation. Transplant Proc 2003; 35: 1900.
  • 20
    Benlloch S, Berenguer M, Prieto M, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 596.
  • 21
    Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25: 1397.
  • 22
    Delcambre F, Pruvot FR, Ramon P, et al. Primary broncogenic carcinoma in transplant recipients. Transplant Proc 1996; 28: 2884.
  • 23
    Frezza EE, Fung JJ, Van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44: 1172.
  • 24
    Jonas S, Rayes N, Neumann U, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141.
  • 25
    Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk of nonlymphoid solid organ tumors. Cancer 1998; 83: 1237.
  • 26
    Peyrégne V, Ducerf C, Adham M, et al. De novo cancer after orthotopic liver transplantation. Transplant Proc 1998; 30: 1484.
  • 27
    Galve ML, Cuervas-Mons V, Figueras J, et al. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc 1999; 31: 1275.
  • 28
    Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 84.
  • 29
    Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001; 7: 971.
  • 30
    Schmilovitz-Weiss H, Mor E, Sulkes J, et al. De novo tumors after liver transplantation: a single-center experience. Transplant Proc 2003; 35: 665.
  • 31
    De Perrot M, Wigle DA, Pierre AF, et al. Broncogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003; 75: 367.
  • 32
    Herrero JI, Lorenzo M, Quiroga J, et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89.
  • 33
    AJCC. Cancer staging handbook. Lung. In: GreeneFL, PageDL, FlemingID, eds. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002: 191203.
  • 34
    Estudio del Carcinoma Broncopulmonar de la SOCALPAR. Incidencia del carcinoma broncopulmonar en Castilla-León durante el año 1997. Estudio multicéntrico de la Sociedad Castellano-Leonesa de Patología Respiratoria (SOCALPAR). Arch Bronconeumol 2000; 36: 313.
  • 35
    Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001; 7: S109.
  • 36
    Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 77: 1777.
  • 37
    Arcasoy SM, Hersh G, Christie JD, et al. Broncogenic carcinoma complicating lung transplantation. J Heart Lung Transplant 2001; 20: 1044.
  • 38
    Rosenbaum DH, Bhojani RA, Dikmen E, et al. Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improved survival. J Heart Lung Transplant 2005; 24: 2043.
  • 39
    The International Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer. The relationship of disease stage to tumor size. Arch Intern Med 2006; 166: 321.
  • 40
    Sanchez de Coss J, Disdier C, Corral J, Riesco JA, Sojo MA, Masa JF. Overall long-term survival in lung cancer analyzed in 610 unselected patients. Arch Bronconeumol 2004; 40: 268.
  • 41
    Pham SM, Kormos RL, Landreneau RJ, et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995; 60: 1623.